DeepMed Research

Fujian Medical University Union Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website: http://www.fjxiehe.com/

Clinical Trials

Comparing Innovative and Traditional Ventilation Strategies on Atelectasis and Prognosis in Elderly Patients

Not Applicable

Recruiting

Conditions: Atelectasis
Ventilator-associated Lung Injury
Postoperative Pulmonary Complications

Interventions: Procedure: Traditional ventilation strategies
Procedure: Traditional lung-protective ventilation strategies
Procedure: Lung-protective ventilation
Procedure: negative pressure extubation
Procedure: Innovative lung-protective ventilation strategies
Procedure: positive pressure extubation
Procedure: postoperative breathing training

First Posted Date: 2023-09-01

Last Posted Date: 2023-09-01

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 304

Registration Number: NCT06021249

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
🇨🇳
The First Hospital of Putian, Putian, Fujian, China

Postoperative Chronic Operation-related Symptoms After Minimally Invasive Lung Surgery

Recruiting

Conditions: Lung Cancer Stage I
Quality of Life

First Posted Date: 2023-08-30

Last Posted Date: 2023-11-18

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 500

Registration Number: NCT06016881

Locations: 🇨🇳
Maohui Chen, Fuzhou, Fujian, China

Personalized Optimization of Systematic Prostate Biopsy

Not Applicable

Recruiting

Conditions: Prostate Adenocarcinoma

Interventions: Procedure: Personalized Optimization of Systematic Prostate Biopsy

First Posted Date: 2023-08-18

Last Posted Date: 2025-02-20

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 664

Registration Number: NCT05998278

Locations: 🇨🇳
Department of Urology, Fujian Union Hospital, Fujian Medical University, Fuzhou, Fujian, China

Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds

Not Applicable

Recruiting

Conditions: Skin Wound
Scar, Hypertrophic

Interventions: Procedure: human umbilical cord mesenchymal stem cells
Procedure: blank solvent

First Posted Date: 2023-08-09

Last Posted Date: 2023-10-24

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 88

Registration Number: NCT05984628

Locations: 🇨🇳
Chenxiaosong, Fujian, Fuzhou, China

Combined Segmentectomy Versus Lobectomy for Stage IA Lung Adenocarcinoma With Ground-glass Component of Prospective, Randomized, Controlled Clinical Study

Not Applicable

Active, not recruiting

Conditions: Combined Segmentectomy
IA Lung Adenocarcinoma

Interventions: Procedure: Patients receive subsegmentectomy

First Posted Date: 2023-08-09

Last Posted Date: 2023-08-09

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 688

Registration Number: NCT05983835

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, China

Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST

Phase 3

Not yet recruiting

Conditions: Gastrointestinal Stromal Tumor of Rectum

Interventions: Drug: Imatinib Mesylate
Procedure: Local resection

First Posted Date: 2023-08-01

Last Posted Date: 2023-08-01

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 23

Registration Number: NCT05970900

Locations: 🇨🇳
Weizhong Jiang, Fuzhou, Fujian, China

Effect of Continuous Intra-airway Monitoring Under Visible Double-lumen Bronchial Catheter on Postoperative Complications of Lung Surgery

Not Applicable

Not yet recruiting

Conditions: Postoperative Pulmonary Complications

Interventions: Procedure: Continuous intra-airway monitoring and intervention during surgey

First Posted Date: 2023-04-26

Last Posted Date: 2023-04-26

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 376

Registration Number: NCT05830474

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Phase 2

Not yet recruiting

Conditions: Immunotherapy;Envafolimab; Esophageal Cancer

Interventions: Drug: Envafolimab
Drug: Abraxane
Drug: Cisplatin

First Posted Date: 2023-04-25

Last Posted Date: 2023-04-25

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 33

Registration Number: NCT05828381

Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma

Phase 2

Not yet recruiting

Conditions: Radiation Therapy
Chemotherapy

Interventions: Drug: Camrelizumab
Drug: Paclitaxel
Radiation: Radiotherapy
Drug: Cisplatin

First Posted Date: 2023-04-20

Last Posted Date: 2023-04-20

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 40

Registration Number: NCT05821452

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, China

Cognitive Changes in Mild Cognitive Impairment

Recruiting

Conditions: Healthy Controls Without Orthostatic Hypotension

Interventions: Other: observational study

First Posted Date: 2023-04-20

Last Posted Date: 2023-04-20

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 200

Registration Number: NCT05821400

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy